Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease.

Autor: Schultheiss JPD; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., Mahmoud R; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., Louwers JM; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., van der Kaaij MT; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., van Hellemondt BP; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., van Boeckel PG; Division of Internal Medicine, Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands., Mahmmod N; Division of Internal Medicine, Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands., Jharap B; Division of Internal Medicine, Department of Gastroenterology and Hepatology, Meander Medical Centre, Amersfoort, The Netherlands., Fidder HH; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., Oldenburg B; Division of Internal Medicine and Dermatology, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Nov; Vol. 54 (10), pp. 1298-1308. Date of Electronic Publication: 2021 Sep 24.